Dynamics of rheological and biochemical blood parameters of patients with an intermediate stage of the dry form of age-related macular degeneration before and after serum cascade filtration

Cover Page

Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription Access

Abstract

BACKGROUND: One of the socially significant ophthalmic diseases is the dry form of the age-related macular degeneration, the key feature of which consists in a slowly progressing damage to the pigment epithelium and the formation of drusen. However, the basic mechanisms of pathogenesis are still not completely clear nowadays.

AIM: The aim is, using the data of OCT, OCT-angiography and visometry, to study the dynamics of structural and functional parameters of the macular area, as well as the dynamics of rheological and biochemical blood parameters in patients with an intermediate stage of the dry form of age-related macular degeneration before and after the use of serum cascade filtration.

MATERIALS AND METHODS: The study included 63 patients (94 eyes) with an intermediate stage of the dry form of age-related macular degeneration. Patients were randomly separated into two groups. The first (main) group consisted of 34 patients (52 eyes), in whom serum cascade filtration was performed; the second group (control) group included 29 patients (42 eyes) who did not receive any specific treatment. In patients of the main group, before and after the serum cascade filtration course (1 month after the start of follow-up), in 6 and 12 months, in addition to standard ophthalmological examination, as an indicator of the efficacy of performed serum cascade filtration, the ultrasound triplex scanning in color Doppler mapping mode with an assessment of blood flow velocity in the posterior short ciliary arteries, Fourier IR spectroscopy, and the testing of the serum and blood viscosity were performed. Patients in the control group also underwent a similar examination at 1, 6, 12 months after the start of follow-up.

RESULTS: According to optical coherence tomography, optical coherence tomography-angiography and visometry data, we found a positive dynamics of structural and functional parameters of the macular retina and an improvement in blood rheological parameters with an increase in microcirculation indices against the background of the serum cascade filtration use in treatment of patients with an intermediate stage of the dry form of age-related macular degeneration. At the same time, a statistically significant difference between the two groups begins at 1 month and persists for 12 months of follow-up, being an evidence of the stabilization of the pathological process.

CONCLUSIONS: This study showed that after the serum cascade filtration in patients with an intermediate stage of the dry form of age-related macular degeneration, against the background of an improvement in blood rheological and biochemical parameters, there was an improvement in structural and functional parameters of the macular area, which consisted in a decrease of the volume of the drusenoid retinal pigment epithelium detachment and in a visual acuity amelioration.

About the authors

Aleksey N. Kulikov

Kirov Military Medical Academy

Email: alexey.kulikov@mail.ru
ORCID iD: 0000-0002-5274-6993
SPIN-code: 6440-7706

MD, Dr. Sci. (Medicine), Professor

Russian Federation, Saint Petersburg

Andrey N. Belskikh

Kirov Military Medical Academy

Email: d0c62@mail.ru
ORCID iD: 0000-0002-0421-3797
SPIN-code: 7764-0930

MD, Dr. Sci. (Medicine), Professor, Corresponding Member of the Russian Academy of Sciences

Russian Federation, Saint Petersburg

Aleksandr A. Volozhev

Kirov Military Medical Academy

Author for correspondence.
Email: aleksandr-volozh@mail.ru
ORCID iD: 0000-0001-5446-5063
SPIN-code: 1269-2220
Russian Federation, Saint Petersburg

Aleksandr V. Podshivalov

Saint Petersburg National Research University of Information Technologies, Mechanics and Optics

Email: podshivalov@itmo.ru
ORCID iD: 0000-0002-7581-8582
SPIN-code: 7008-7636

Cand. Sci. (Chemistry)

Russian Federation, Saint Petersburg

Vera E. Sitnikova

Saint Petersburg National Research University of Information Technologies, Mechanics and Optics

Email: kresenka@mail.ru
ORCID iD: 0000-0003-4753-976X
SPIN-code: 1003-2636

Cand. Sci. (Chemistry), Assistant Professor

Russian Federation, Saint Petersburg

Dmitrii S. Maltsev

Kirov Military Medical Academy

Email: glaz.med@yandex.ru
ORCID iD: 0000-0001-6598-3982
SPIN-code: 4903-2333

MD, Dr. Sci. (Medicine)

Russian Federation, Saint Petersburg

Svetlana E. Bednova

Kirov Military Medical Academy

Email: sebednova@mail.ru
ORCID iD: 0009-0006-3960-7346
Russian Federation, Saint Petersburg

References

  1. Izmaylov AS. Treatment of a “dry” form of age-related macular degeneration. RMJ. Clinical Ophthalmology. 2017;1:56-60. (In Russ.) EDN: YTFDXF doi: 10.21689/2311-7729-2017-17-1-56-60
  2. Donders FC. Contributions to the pathological anatomy of the eye. Contributions to the pathological anatomy of the eye. Archiv für Ophthalmologie. 1855;1:106–118. (In German.)
  3. Hutchinson J. Symmetrical central choroido-retinal disease occurring in senile persons // The Royal London Ophthalmic Hospital Records and Journal of Ophthalmic Medicine And Surgery. 1874. P. 231–244.
  4. Haab O. Erkrankungen der Macula lutea. Disaes of the macula lutea. Centralblat für praktische Augenheilkunde. 1885. P. 384–391. (In German.)
  5. Haab O. Atlas und Grundriss der Ophthalmoskopie und ophthalmoskopischen Diagnostik. Atlas and outline of ophthalmoscopy and ophthalmoskopic diagnostics. Lehmann: München, 1908. P. 2. (In German.)
  6. Gass JD. Drusen and disciform macular detachment and degeneration. Arch Ophthalmol. 1973;90(3):206–217. doi: 10.1001/archopht.1973.01000050208006.
  7. Liebman ES, Shakhova EV. Blindness and disability due to pathology of the organ of vision in Russia. The Russian Annals of Ophthalmology. 2006;122(1):209–2014. (In Russ.) EDN: YTFDXF
  8. Konyaev DA, Popova EB, Titov AA, et al. The prevalence of eye diseases in the elderly population is a global problem of modernity. Health Care of the Russian Federation. 2021;65(1):62–68. (In Russ.) EDN: RCSSVB doi: 10.47470/0044-197X-2021-65-1-62-68
  9. Stahl A. The diagnosis and treatment of age-related macular degeneration. Dtsch Arztebl Int. 2020;117(29–30):513–520. doi: 10.3238/arztebl.2020.0513
  10. Wong WL, Su X, Li X, et al. Global prevalence of age-related macular degeneration and disease burden projection for 2020 and 2040: a systematic review and meta-analysis. Lancet Glob Health. 2014;2(2):e106–e116. doi: 10.1016/S2214-109X(13)70145-1
  11. Roh M, Laíns I, Shin HJ, et al. Microperimetry in age-related macular degeneration: association with macular morphology assessed by optical coherence tomography. Br J Ophthalmol. 2019;103(12):1769–1776. doi: 10.1136/bjophthalmol-2018-313316
  12. Johnson PT, Lewis GP, Talaga KC, et al. Drusen-associated degeneration in the retina. Invest Ophthalmol Vis Sci. 2003;44(10): 4481–4488. doi: 10.1167/iovs.03-0436
  13. De Jong PTVM. Elusive drusen and changing terminology of AMD. Eye (Lond). 2018;32(5):904–914. doi: 10.1038/eye.2017.298
  14. Manuilov AS, Bardakov SN, Apchel AV, et al. The experience of using cascade plasmofiltration in combined treatment with systemic lupus erythematosus on the background of programmed hemodialysis. Bulletin of the Russian Military Medical Academy. 2018;20(2):115–119. (In Russ.) EDN: XRZEVF doi: 10.17816/brmma12278/
  15. Chew EY, Clemons TE, Agrón E, et al.; AREDS2 Research Group. Long-term outcomes of adding lutein/zeaxanthin and ω-3 fatty acids to the AREDS supplements on age-related macular degeneration progression: AREDS2 Report 28. JAMA Ophthalmol. 2022;140(7): 692–698. doi: 10.1001/jamaophthalmol.2022.1640
  16. Huang Z, Deng KY, Deng YM, et al. Long-term outcomes of drusenoid pigment epithelium detachment in intermediate AMD treated with 577 nm subthreshold micropulse laser: a preliminary clinical study. Int J Ophthalmol. 2022;15(3):474–482. doi: 10.18240/ijo.2022.03.16
  17. Guymer RH, Wu Z, Hodgson LAB, et al. Laser intervention in early stages of age-related macular degeneration study group. Subthreshold nanosecond laser intervention in age-related macular degeneration: the lead randomized controlled clinical trial. Ophthalmology. 2019;126(6):829–838. doi: 10.1016/j.ophtha.2018.09.015
  18. Brunner R, Widder RA, Walter P, et al. Influence of membrane differential filtration on the natural course of age-related macular degeneration — a randomized trial. Retina. 2000;20:483–491. doi: 10.1097/00006982-200009000-00009
  19. Swartz M, Rabetoy G. Treatment of non-exudative agerelated macular degeneration using membrane differential filtration apheresis. Invest Ophthalmol Vis Sci. 1999;40:319.
  20. Klingel R, Fassbender C, Heibges A, et al. Rheo Net registry analysis of rheopheresis for microcirculatory disorders with a focus on age-related macular degeneration. Ther Apher Dial. 2010;14(3): 276–286. doi: 10.1111/j.1744-9987.2010.00807.x
  21. Maltsev DS, Kulikov AN, Chkhablani D, et al. Optical coherence tomography in the diagnosis and treatment of central serous chorioretinopathy. Bulletin of Ophthalmology. 2018;134(6):15–24. (In Russ.) EDN: VTAFQB doi: 10.17116/oftalma201813406115

Supplementary files

Supplementary Files
Action
1. JATS XML
2. Fig. 1. Representative example of the drusenoid retinal pigment epithelium detachment area calculation in a patient with the dry form of age-related macular degeneration. Structural en face scan projection of the “HD Angio Retina 6 mm” protocol

Download (446KB)
3. Fig. 2. Representative example of the result of the Fourier IR spectroscopy analysis in a patient with the dry form of age-related macular degeneration

Download (127KB)
4. Fig. 3. Representative example of the result of an analysis of the blood serum viscosity in a patient with the dry form of age-related macular degeneration

Download (109KB)
5. Fig. 4. Example of structural and anatomical changes dynamics after the use of the serum cascade filtration in patients with the dry form of age-related macular degeneration according to the OCT and OCT-A data during the study: a — start of the follow-up; b — in 1 month; c — 6 months; d — 12 months

Download (502KB)
6. Fig. 5. Dynamics of the drusenoid retinal pigment epithelium detachment height in studied groups

Download (113KB)
7. Fig. 6. Dynamics of the drusenoid retinal pigment epithelium detachment area in studied groups

Download (94KB)
8. Fig. 7. Dynamics of visual acuity in studied groups: a — using the ETDRS chart; b — using the Golovin–Sivtsev chart

Download (145KB)

Copyright (c) 2024 Eco-Vector

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
 


This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies